Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

New antibiotic launched

  • Comment
A new carbapenem antibiotic, doripenem (Doribax), has been launched for the treatment of complicated intra abdominal infections, as well as nosocomial pneumonia and ventilator associated pneumonia in adult patients.

Doripenem, developed by Janssen-Cilag, is a broad-spectrum, intravenous antibiotic with activity against a wide range of Gram-positive and Gram-negative pathogens and was developed to meet a rapidly growing need for new antibiotics as hospital bacteria become increasingly resistant to existing antibiotic therapies.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs